Cargando…
Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box
Chemical matter is needed to target the divergent biology associated with the different life cycle stages of Plasmodium. Here, we report the parallel de novo screening of the Medicines for Malaria Venture (MMV) Pandemic Response Box against Plasmodium asexual and liver stage parasites, stage IV/V ga...
Autores principales: | Reader, Janette, van der Watt, Mariëtte E., Taylor, Dale, Le Manach, Claire, Mittal, Nimisha, Ottilie, Sabine, Theron, Anjo, Moyo, Phanankosi, Erlank, Erica, Nardini, Luisa, Venter, Nelius, Lauterbach, Sonja, Bezuidenhout, Belinda, Horatscheck, Andre, van Heerden, Ashleigh, Spillman, Natalie J., Cowell, Anne N., Connacher, Jessica, Opperman, Daniel, Orchard, Lindsey M., Llinás, Manuel, Istvan, Eva S., Goldberg, Daniel E., Boyle, Grant A., Calvo, David, Mancama, Dalu, Coetzer, Theresa L., Winzeler, Elizabeth A., Duffy, James, Koekemoer, Lizette L., Basarab, Gregory, Chibale, Kelly, Birkholtz, Lyn-Marié |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801607/ https://www.ncbi.nlm.nih.gov/pubmed/33431834 http://dx.doi.org/10.1038/s41467-020-20629-8 |
Ejemplares similares
-
Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination
por: Reader, Janette, et al.
Publicado: (2015) -
Differential activity of novel gametocytocidal compounds: drug mode-of-action and ex vivo efficacy
por: Birkholtz, Lyn-Marie, et al.
Publicado: (2014) -
The ecdysone receptor regulates several key physiological factors in Anopheles funestus
por: Maharaj, Surina, et al.
Publicado: (2022) -
H3K36 methylation reprograms gene expression to drive early gametocyte development in Plasmodium falciparum
por: Connacher, Jessica, et al.
Publicado: (2021) -
Plasmodial Kinase Inhibitors: License to Cure?
por: Cabrera, Diego González, et al.
Publicado: (2018)